2 Growth Stocks Worth Buying Through the Volatility and Holding for a Lifetime

E.l.f. Beauty reported fiscal 2026 net sales of $1.64 billion, up 25% year over year, with 29 consecutive quarters of double-digit growth and expansion across all five brands. Vita Coco posted Q1 2026 net sales of $180 million, up 37%, beat expectations by more than 22%, expanded operating margin to 18.7%, and raised full-year revenue guidance to $720 million-$735 million. The article is broadly constructive on both companies' long-term compounding prospects, driven by acquisitions, international expansion, and category leadership.

Analysis

The cleaner read-through is that both names are beneficiaries of a premiumization and shelf-space reallocation cycle inside consumer staples/beauty, not just idiosyncratic execution. When a smaller brand posts sustained growth while incumbents stay in low single digits, retailers tend to allocate incremental facings to the faster-turning SKU set, which creates a feedback loop in velocity and bargaining power. That dynamic is more durable for ELF than the headline growth rate suggests because it can use acquisitions to step up-market without abandoning its value-core franchise.

The second-order effect for legacy beauty is margin pressure, not just share loss. If ELF keeps taking premium-adjacent demand through rhode while maintaining affordability at the base layer, the category’s mid-tier brands get squeezed from both sides: consumers trade down on price and trade up on aspiration. The same logic applies to COCO in beverages, where a dominant branded leader with a private-label backstop can force weaker regional entrants into lower gross-margin channels or out of distribution entirely.

For COCO, the underappreciated catalyst is that international adoption can matter more than U.S. household penetration from here. A small improvement in European or emerging-market velocity can compound disproportionately because the fixed-cost distribution network is already built; that makes guidance revisions likely to continue if volume stays ahead of price. The main risk is that investors extrapolate a single strong quarter into a straight-line category TAM story; if household budgets weaken further, coconut water can be treated as a discretionary wellness purchase, and the growth multiple can compress faster than earnings.

The contrarian view is that the market may be underpricing quality at COCO and overpricing narrative optionality at ELF. ELF has more moving parts after M&A, which raises integration and brand-dilution risk over a 6-12 month horizon, whereas COCO’s simpler model gives cleaner earnings visibility and better downside support. If consumer spending softens, the right trade may be a relative long in the more self-funding category leader versus the acquisition-heavy compounder.

Key Decisions for Investors

• Long COCO on any post-earnings consolidation; target a 6-12 month hold with upside driven by continued guidance raises and operating leverage, but trim if the stock re-rates far ahead of revisions.
• Pair trade: long COCO / short a basket of slower-growth beauty incumbents if available, or long COCO / short XLY-discretionary proxy, to isolate category leadership and limit consumer-spending beta.
• In ELF, wait for a pullback rather than chasing strength; use a 3-6 month horizon and size smaller because acquisition integration and brand mix dilution create asymmetric disappointment risk after a strong run.
• For more tactical exposure, buy COCO call spreads 3-4 months out around the next earnings cycle to express continued guidance upside with defined risk; the setup favors a modest multiple expansion if volumes stay >20%.